| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.46 | - | - |
| Q3'25 | $0.41 | $0.46 | +10.9% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $207M | - | - |
| Q3'25 | - | $189M | - |
Market Data
RGEN is currently trading at $181.62, giving Repligen Corporation a market cap of 9.43B and a P/E ratio of 227.0. Today's range spans $176.28–$183.05, with shares opening at $180.60 and moving down $0.06 (0.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 67/100.
Over the past year RGEN has traded between $100.99 and $188.73 - the current price is +79.8% off the 52-week low and -3.8% from the high.
RGEN is a small-cap the broader market name (9.43B market cap) with a BUY technical read (82/100) and bullish sentiment (67/100). Price: $181.62 (near 52-week highs). (P/E: 227.0) The 52-week window of $100.99–$188.73 shows the full range this stock can trade - and at this cap tier, once momentum builds, the move from near 52-week highs to either extreme tends to happen faster than the timeline in larger-cap names.
News sentiment (67/100, bullish) plays a larger role in small-cap price discovery than in mega-cap names, because the analyst coverage base is narrower and each incremental news item carries more weight in the information set. For RGEN, 9.43B in the broader market market cap, technical score 82/100 (BUY), price $181.62 (near 52-week highs), a sustained improvement in the news backdrop could accelerate the bullish technical thesis toward the upper end of the $100.99–$188.73 range faster than fundamental models would suggest.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.